Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Apomorphine (VR040) for 'Off' Periods in Parkinson's Disease
NCT01683292Phase 2Completed
- Sponsor
- South Glasgow University Hospitals NHS Trust
- Start
- Jan 2006
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apomorphine in Parkinson's disease (PD), sponsored by South Glasgow University Hospitals NHS Trust. Started Jan 2006; status: completed.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01683292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01683292.